Mark Opdam

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Marcelo Sobral‐Leite, Izhar Salomon, Mark Opdam et al. · Breast Cancer Research · 2019 · 131 citations · Full text

Medicine, Immunology, Oncology +15

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

Vincent M. T. de Jong, Yuwei Wang, Natalie D. ter Hoeve et al. · Zurich Open Repository and Archive (University of Zurich) · 2022 · 103 citations · Full text

Medicine, Immunology, Oncology +11

Deep learning-based breast cancer grading and survival analysis on whole-slide histopathology images

Suzanne C. Wetstein, Vincent M. T. de Jong, Nikolas Stathonikos et al. · Scientific Reports · 2022 · 103 citations · Full text

Medicine, Oncology, Pathology +17

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

Karin Beelen, Mark Opdam, Tesa Severson et al. · Breast Cancer Research · 2014 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment

Karin Beelen, Mark Opdam, Tesa Severson et al. · Breast Cancer Research · 2014 · 48 citations · Full text

Medicine, Oncology, Pharmacology +16